Summit Place Financial Advisors’s Elevance Health ELV Stock Holding History

Summit Place Financial Advisors’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-542	Closed	-$211K	–	104
2025 Q2	$211K	Hold	542	–	–	0.11%	87
2025 Q1	$236K	Buy	+542	New	+$218K	0.13%	89
2024 Q4	–	Sell	-542	Closed	-$282K	–	93
2024 Q3	$282K	Buy	542 +17	+3%	+$9.08K	0.16%	81
2024 Q2	$284K	Hold	525	–	–	0.17%	82
2024 Q1	$272K	Hold	525	–	–	0.16%	82
2023 Q4	$248K	Hold	525	–	–	0.16%	83
2023 Q3	$229K	Hold	525	–	–	0.16%	87
2023 Q2	$233K	Hold	525	–	–	0.15%	86
2023 Q1	$241K	Hold	525	–	–	0.17%	87
2022 Q4	$269K	Hold	525	–	–	0.22%	77
2022 Q3	$238K	Hold	525	–	–	0.22%	81
2022 Q2	$253K	Hold	525	–	–	0.21%	91
2022 Q1	$258K	Hold	525	–	–	0.17%	100
2021 Q4	$243K	Sell	525 -45	-8%	-$18.9K	0.17%	96
2021 Q3	$212K	Sell	570 -30	-5%	-$11.4K	0.15%	103
2021 Q2	$229K	Hold	600	–	–	0.17%	99
2021 Q1	$215K	Buy	+600	New	+$193K	0.17%	100

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Summit Place Financial Advisors's ELV Position: Q3 2025 in Review

Summit Place Financial Advisors sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 542 shares — an estimated $211K sold.

Summit Place Financial Advisors first reported a position in ELV in Q1 2021 and held it in 17 quarters. The position peaked at $284K in Q2 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

Summit Place Financial Advisors reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
Summit Place Financial Advisors sold 542 Elevance Health shares in Q3 2025, an estimated $211K.
Summit Place Financial Advisors first reported a position in Elevance Health in Q1 2021 and held it in 17 quarters.
Summit Place Financial Advisors's Elevance Health position peaked at $284K in Q2 2024.
1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on Summit Place Financial Advisors's 13F filing for Q3 2025, filed 23 Oct 2025.